Results 221 to 230 of about 72,943 (311)

Swallowing and Communication in Cockayne Syndrome: Clinical Characteristics and Management

American Journal of Medical Genetics Part A, Volume 200, Issue 7, Page 1465-1478, July 2026.
ABSTRACT Cockayne syndrome (CS) is an ultrarare genetic disorder associated with genes encoding proteins involved in DNA repair. The clinical course of CS involves neurodevelopmental and neurodegenerative features, including swallowing and communication impairments.
Abigail M. Spoden, Katlyn E. McGrattan, Peter B. Kang   +2 more
wiley   +1 more source

Cost-effectiveness of RefluxStop for gastroesophageal reflux disease: analysis from an Italian healthcare perspective. [PDF]

BMC Gastroenterol
Harper S, Kartha M, Mealing S, Bona D, Vincenti L, Renzi A, Bonavina L.   +6 more
europepmc   +1 more source

Gastrointestinal Manifestations in Rubinstein‐Taybi Syndrome

American Journal of Medical Genetics Part A, Volume 200, Issue 7, Page 1491-1497, July 2026.
ABSTRACT Rubinstein–Taybi syndrome is a rare genetic condition associated with a wide range of physical, cognitive, and developmental impairments, yet its gastrointestinal manifestations remain poorly characterized. Case reports and small series suggest a high prevalence of gastroesophageal reflux, constipation, dysphagia, and nutritional compromise ...
Mohamad Abi Nassif, Ajay Kaul, Lev Dorfman, Khalil El‐Chammas   +3 more
wiley   +1 more source

Can bile salts affect the contractile oesophageal activity associated with gastroesophageal reflux disease? [PDF]

World J Gastroenterol
Gadelha KKL, Santos AA, Correia-de-Sá P, Magalhães PJC, da Silva MTB.   +4 more
europepmc   +1 more source

Ocrelizumab‐induced colitis: VigiBase disproportionality analysis, case reports and literature review

British Journal of Clinical Pharmacology, Volume 92, Issue 7, Page 2162-2170, July 2026.
Aims Ocrelizumab is a humanized anti‐CD20 monoclonal antibody used in multiple sclerosis. Since its commercialization, several cases of ocrelizumab‐induced colitis have been reported in the scientific literature. Methods To explore the potential association of ocrelizumab with colitis as an adverse drug reaction (ADR), we conducted a descriptive and ...
Audrey Fresse, Christophe Hommel, Nadine Petitpain, Philippe Kerschen   +3 more
wiley   +1 more source

Exploring the Factors Influencing the Non‐Prescription Use of Medication in Bangladesh: A Cross‐Sectional Study

Health Science Reports, Volume 9, Issue 7, July 2026.
ABSTRACT Background and Aims Use of non‐prescription drugs is a significant health concern for the population in Bangladesh. The ease of access to medicines, the high price of healthcare and lack of information on how to take the drugs properly promote such a practice.
Sumaia Rahman, S. M. Mahadi Hasan, Md. Omar Faruk, Md. Aminul Islam Nur, Mst. Hajera Khatun   +4 more
wiley   +1 more source

Thal versus Nissen fundoplication for the management of pediatric gastroesophageal reflux disease: a systematic review and meta-analysis. [PDF]

Ann Med Surg (Lond)
Mohamed SF, Elsary A, Abdelnasser M, Alsharif B, Jawad T, Askar AS.   +5 more
europepmc   +1 more source

Relative Contributions of Gastrointestinal‐Specific Hypervigilance and Anxiety in Explaining Eating Disorder Symptoms

Journal of Clinical Psychology, Volume 82, Issue 7, Page 1078-1085, July 2026.
ABSTRACT Objective Gastrointestinal (GI) disturbances and eating disorder symptoms commonly co‐occur. Hypervigilance and anxiety about GI symptoms may motivate eating disorder behaviors to manage and/or avoid GI symptoms. We hypothesized that GI‐specific anxiety would be more strongly associated with dietary restriction and purging than GI‐specific ...
Gabriella Pucci, Naomi G. Hill, Zoe Schneider, Tiffany A. Brown, Helen Burton‐Murray, Livia Guadagnoli, K. Jean Forney   +6 more
wiley   +1 more source

Comparative efficacy and safety of fexuprazan versus esomeprazole in gastroesophageal reflux disease: a systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Abureesh O, Sohail A, Yousef Y, Abureesh A, Abdulraheem A, Tam R, Abou Yassine A, Altork N, Vankayala USA, Chalhoub J, Andrawes S, El Douaihy Y.   +11 more
europepmc   +1 more source

JAK Inhibition in PNPT1‐Related Mitochondrial Interferonopathy: A Case Report and Review of Mitochondrial–Immune Crosstalk

JIMD Reports, Volume 67, Issue 4, July 2026.
ABSTRACT Biallelic pathogenic variants in PNPT1 cause combined oxidative phosphorylation deficiency 13 (COXPD13) (MIM #614932), linking mitochondrial dysfunction to type I interferon (IFN) activation through cytosolic leakage of mitochondrial double‐stranded RNA (mt‐dsRNA).
Dan Ross Brooks, Hyun Yong Koh, Taylor Martin Kerrins, Steven Lang, Emily Bland, Rui Yang, Sarah Kogan Nicholas, Stephanie Jean Sikkink, Stephen Kralik, Christine Eng, Chaya Nautiyal Murali, Seema Lalani, Pilar Lenglet Magoulas, Lisa Emrick, Kristen Sydney Fisher, Fernando Scaglia   +15 more
wiley   +1 more source